Clinical benefits of PD-1/PD-L1 inhibitors in advanced hepatocellular carcinoma: a systematic review and meta-analysis
Quan Rao, Min� Li, Wei Xu, Kai Pang, Xiaobo Guo, Dong Wang, Jun Liu, Wei Guo, ZhongTao Zhang
Topics & Concepts
MedicineInternal medicineMeta-analysisHepatocellular carcinomaOncologyAdverse effectCochrane LibraryClinical trialSorafenibConfidence intervalSubgroup analysisGastroenterologyHepatocellular Carcinoma Treatment and PrognosisCancer Immunotherapy and BiomarkersCholangiocarcinoma and Gallbladder Cancer Studies